To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. 

Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

Publications

  • News for the week of September 3, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Justin J. Bates begins new tenure at OPA as new CEO
    • Materials to help in the fight against the opioid crisis

    • OPA Pharmacy Technician Bundle
    • OPA Clinical Bundle
    • OPA Operational Bundle

    • Are you taking advantage of your membership benefits?

    • Overage dependent coverage

    • Health Product InfoWatch - Safety Updates: Cymbalta, Istodax

  • News for the week of August 27, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Draft regulations for expanded scope of practice now open for public consultation
    • Diabetes resources available from the Diabetes Pharmacists Network at the University of Toronto Banting & Best Diabetes Centre

    • The Master Plan for Diabetes Continuing Education Program
    • Medical Devices Training for Pharmacy Technicians
    • Rational Prescribing: Re-thinking Medications

    • New OPA Benefit: The Manulife All-In Banking™ Package Is Here!
    • Ask the Customer Experience and Administration Team

    • Professional Liability Insurance Claims Reporting

    • DDD Notice No. 19123 Posted August 23, 2019 ODB Formulary – Edition No. 43, Summary of Changes – August 2019 Summary of Product Changes

  • News for the week of August 20, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Tell us your thoughts on draft regulations for expanded scope of practice
    • ICYMI: TELUS Health changes to Pharmacy Manual

    • Paid Consultations - Opportunities and Timesavers
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • Identifying Drug Interactions

    • Manulife All-in-Banking now available to OPA members with exclusive opportunities
    • Ask the Practice Support Network
    • Dell Canada back-to-school Member Purchase Plan deals!
    • Are you taking advantage of your OPA membership?

    • OPA Pharmacy (Store) Insurance

    • Drug Shortage / Supply Health System Alert: Pfizer Leucovorin 50ml

  • News for the week of August 13, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Drug Pricing Regulation Changes
    • Prescription Forgery and Theft Resources
    • Lyme Disease Resources

    • Collaborating with Family Physicians: The Rx for Success
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists
    • Essential Cannabis Knowledge For Pharmacy Technicians Program

    • Ask the Customer Experience and Administration Team
    • Last Chance to Optimize Savings for CNE Tickets!

    • How Do I Choose the Right Life Insurance?


    • Drug Shortage / Supply Health System Alert: Pfizer ANSYR Syringes Backorder - Multiple Products Affected (Calcium Chloride, Dextrose, Lidocaine)
    • Drug Shortage / Supply Health System Alert: Leucovorin and Fludarabine
    • Drug Shortage / Supply Health System Alert: Erwinase
    • Drug Shortage / Supply Health System Alert: Daunorubicin 20mg vial

    • DDD Notice No. 19118 posted August 8, 2019 Prescription Forgery Alert
    • DDD Notice No. 19119 posted August 8, 2019 Prescription Forgery Alert

  • News for the week of August 6, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Pharmacy Updates
    • August is National Drug Drop-Off Month

    • Gastrointestinal Conditions
    • OPA Clinical Bundle
    • Essential Cannabis Knowledge For Pharmacy Technicians Program

    • Ask the Practice Support Network

    • Is Your Financial Future In Order?

    • Drug Shortage / Supply Health System Alert: Leucovorin Supply Status Update

    • DDD Notice No. 19116 posted August 2, 2019 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies

  • News for the week of July 30, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ontario Garners Attention on Drug Shortages Amidst Cross-border Shopping on Insulin
    • University of Toronto Leslie Dan Faculty of Pharmacy Awarded Research Funding for Key Projects
    • Pharmacy Technician Conference - May 9, 2020

    • Women's Health Conditions
    • Medical Devices Training For Pharmacy Technicians
    • Delivering A Comprehensive Pharmacy-Based Vaccines Program

    • Ask the Customer Experience and Administration Team

    • Auto and Home Insurance

    • Drug Shortage / Supply Health System Alert: Succinylcholine 20mg/ml US-based Product (Quelicin)

    • Status of non-absorbable synthetic surgical mesh for the transvaginal repair of pelvic organ prolapse in Canada
    July Issue of Health Product InfoWatch

  • News for the week of July 23, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Advocates for Seniors Healthcare Services in Public Consultation
    • EpiPen 0.3 mg Auto-Injector Shortages
    • Sherry Peister Named Recipient of The Canadian Foundation for Pharmacy Pillar of Pharmacy Award

    • Identifying Drug Interactions
    • Implementing Smoking Cessation Services in the Pharmacy
    • Assessing and Prescribing for Minor Ailments – Full Program

    • Ask the Practice Support Network
    • Summer Member Discounts!
    • Member Benefit: RxFiles
    • Bonus Offer from TELUS

    • Do I Need Life insurance?

    • DDD Notice No. 19114 posted July 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – July 2019
    • DDD Notice No. 19113 posted July 18, 2019 Prescription Forgery Alert

    • Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching Between Different Oral Formulations
    • Pfizer Canada is Reporting a Shortage of EpiPen (0.3 mg) Auto-Injectors and Taking Precautions to Minimize Impact on Canadians

  • News for the week of July 16, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Justin J. Bates Joins OPA as Chief Executive Officer
    • Last chance to participate in OPA’s Member Survey on Immunization
    • Health Canada finalizes regulations for the production and sale of edible cannabis, cannabis extracts and cannabis topicals

    • Asthma Management: The Essentials
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Opioid Addictions and Substitution Therapy Online Modules

    • Ask the Customer Experience and Administration Team
    • Summer Member Discounts!
    • Summer of Space at the Ontario Science Centre
    • Member Benefit: RxFiles
    • Bonus Offers from TELUS

    • How do I benefit from OPA’s Long Term Disability Insurance?

    • DDD Notice No. 19111 posted July 11, 2019 Drug Shortage / Supply Health System Alert: Rifampin

  • News for the week of July 9, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Introducing the 2019-20 OPA Board of Directors
    • OPA 2018-19 Annual Report: Shifting Resilience
    • OPA Survey on Immunization
    • Benefits of Immunization - Report from the International Federation on Ageing
    • University of Toronto Leslie Dan Faculty of Pharmacy Appointments
    • Medical Cannabis Users Survey Results: 1 in 4 medical cannabis users say it's now harder to access cannabis since recreational legalization

    • Injections and Immunizations Certificate Program
    • The Master Plan for Diabetes Continuing Education Program
    • Collaborating with Family Physicians: The Rx for Success

    • Ask the Practice Support Network
    • Summer member discounts!

    • Why Choose OPA Disability Insurance?

    • DDD Notice No. 19106 posted July 5, 2019 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
    • DDD Notice No. 19105 posted July 5, 2019 Notice from the Executive Officer
    • DDD Notice No. 19104 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19103 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19102 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19101 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19100 posted July 5, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Rofact (rifampin)
    • Drug Shortage / Supply Health System Alert: Rifampin
    • Drug Shortage / Supply Health System Alert: Leucovorin
    • Drug Shortage / Supply Health System Alert: Leucovorin, Fludarabine, Jevtana (Cabazitaxel)

  • News for the week of July 2, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Drug Supply Health System Alert: Fludarabine Phosphate Injection and Leucovorin Calcium Injection
    • Reminder: Call for OPA Committee Members
    • Call for abstracts - 2020 Traumatic Brain Injury Conference

    • Managing Your Pharmacy: The Business Essentials
    • Essential Cannabis Knowledge for Pharmacy Technicians
    • Assessing and Prescribing for Minor Ailments - Full program

    • Ask the Customer Experience and Administration Team
    • Summer deals with Dell member savings!

    • Stay insured when leaving the country with OPA’s Emergency Travel Insurance

    • Certain older Medtronic MiniMed insulin pumps may be vulnerable to cybersecurity risks
    • Health Product InfoWatch - Vaccine safety biannual summary and pms-Methotrexate monograph update

Back to top